Arpit Almal

Title: Arpit Almal: Innovator in Colorectal Cancer Prognostics

Introduction

Arpit Almal is a notable inventor based in Gujarat, India. He has made significant contributions to the field of cancer research, particularly in the area of colorectal cancer. His innovative work focuses on developing tools that can aid in predicting cancer recurrence, which is crucial for patient management and treatment strategies.

Latest Patents

Arpit Almal holds a patent for a groundbreaking assay system titled "Prognostic signature for colorectal cancer recurrence." This system is designed to predict the recurrence and/or non-recurrence of colorectal cancer in patients. The assay analyzes patient samples for the quantitative expression of a prognostic genetic profile that correlates with cancer recurrence. The profile includes the expression of specific nucleic acid sequences identified as SEQ ID NOS: 1, 2, 3, 4, and 5. This patent represents a significant advancement in personalized medicine and cancer treatment.

Career Highlights

Arpit Almal is currently associated with Everist Genomics, Inc., where he continues to work on innovative solutions in genomics and cancer diagnostics. His expertise and dedication to research have positioned him as a valuable asset in the field of medical technology.

Collaborations

Throughout his career, Arpit has collaborated with esteemed colleagues, including William P. Worzel and Peter F. Lenehan. These collaborations have further enhanced his research and contributed to the development of effective diagnostic tools.

Conclusion

Arpit Almal's contributions to colorectal cancer research through his innovative patent and work at Everist Genomics, Inc. highlight his commitment to improving patient outcomes. His efforts in developing predictive tools for cancer recurrence are paving the way for advancements in personalized medicine.